Results 171 to 180 of about 295,973 (347)
This article introduces a national, multicenter, prospective, non‐interventional, observational registry study, which established a comprehensive and sustainable database of lower respiratory tract infection in children. This database will help improve the scientific research efficiency of clinicians and facilitate the exploration of underlying ...
Yu Deng+40 more
wiley +1 more source
Microbiota diversity and differences in the respiratory tract of children with pneumonia
Differences in microbial communities in the upper and lower respiratory tract in patients with pneumonia were investigated in this study by sequencing the 16S rRNA genes in pharyngeal swabs and alveolar lavage fluid. Forty‐three subjects were enrolled in the study, and one upper and one lower respiratory tract sample were collected from each subject ...
Dandan Ge+4 more
wiley +1 more source
Pandemic Influenza A/H1N1 Viral Pneumonia without Co-Infection in Korea: Chest CT Findings [PDF]
Jun Seong Son+9 more
openalex +1 more source
ABSTRACT Respiratory syncytial virus (RSV) is one of the most common respiratory pathogens in children under 5 years of age worldwide and it seriously threatens children's health. In recent years, great progress has been made in the field of RSV‐related diseases.
Committee of Pediatrics+16 more
wiley +1 more source
8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis
Takaaki Akaike+8 more
openalex +1 more source
This review explores improved tetracycline (TCN) delivery via polymer‐based nanocarriers to enhance solubility, stability, and targeted release. It also covers stimuli‐responsive systems, triggered by pH, enzymes, or reactive oxygen species (ROS), and co‐delivery approaches that increase therapeutic efficacy in cancer and inflammatory diseases ...
Mahsa Molaei Nasr+5 more
wiley +1 more source
Impact of viral infections in children with community‐acquired pneumonia: results of a study of 17 respiratory viruses [PDF]
Susanna Esposito+8 more
openalex +1 more source
A systematic review and meta‐analysis were conducted to review all clinical trial results of anifrolumab for treating systemic lupus erythematosus. Fourteen studies were included comprising 1322 patients and five studies were meta‐analyzed. It was found that anifrolumab 300 mg IV led to clinical improvement across composite lupus scores, cutaneous ...
Yomna W. Mahmoud+11 more
wiley +1 more source
Medical treatment of viral pneumonia including SARS in immunocompetent adult
Vincent Chi‐Chung Cheng+4 more
openalex +1 more source